David Auslander

Senior Principal Scientist / Group Head at Novartis Institutes for BioMedical Research (NIBR) - Cambridge, Massachusetts, US

David Auslander's Colleagues at Novartis Institutes for BioMedical Research (NIBR)
Rene Wyler

Head Discovery Technologies GDC (Global Discovery Chemistry)

Contact Rene Wyler

Dominic Ehrismann

Director, Search & Evaluation, BD&L

Contact Dominic Ehrismann

Eusebio Manchado

Group Leader, Associate Director

Contact Eusebio Manchado

Jean Quancard

Executive Director, Discovery Chemistry

Contact Jean Quancard

Andrea Widhalm

Senior Principal Business Operations

Contact Andrea Widhalm

Valerie Salazar

Senior Principal Scientist

Contact Valerie Salazar

Brigitte Schiessl

Global Program Manager bei Novartis Translational Clinical Oncology

Contact Brigitte Schiessl

View All David Auslander's Colleagues
David Auslander's Contact Details
HQ
617-871-8000
Location
Basel,Basel-Stadt,Switzerland
Company
Novartis Institutes for BioMedical Research (NIBR)
David Auslander's Company Details
Novartis Institutes for BioMedical Research (NIBR) logo, Novartis Institutes for BioMedical Research (NIBR) contact details

Novartis Institutes for BioMedical Research (NIBR)

Cambridge, Massachusetts, US • 3974 Employees
Major Drugs

Our people With more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine. NIBR focuses on the following disease areas: • Autoimmunity, Transplantation, and Inflammatory Disease • Cardiovascular & Metabolic Diseases • Immuno-oncology • Infectious Diseases • Musculoskeletal Diseases • Neuroscience • Oncology • Ophthalmology • Respiratory Diseases NIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms. • Analytical Sciences • Biologics • Biomarker Development • Chemistry • Developmental and Molecular Pathways • Drug Metabolism & Pharmacokinetics • Genomics Institute of the Novartis Research Foundation › Developing advanced technologies, ranging from cellular genomics and proteomics to combinatorial chemistry and structural biology • Imaging • Metabolism and Pharmacokinetics • Preclinical Safety • Proteomic Chemistry • Translational Medicine NIBR has locations in: • Basel, Switzerland • Cambridge, MA • East Hanover, NJ • Emeryville, CA (SF Bay Area) • San Diego, CA • Shanghai, China Thank you for taking an interest in the NIBR LinkedIn page. Please read Novartis' LinkedIn community guidelines: https://bit.ly/3yAl483

Gnf Cardiac Repari Novartis La Jolla Genomics Institute Of The Novartis Research Foundation Novartis Genomics Shifeng Novartis
Details about Novartis Institutes for BioMedical Research (NIBR)
Frequently Asked Questions about David Auslander
David Auslander currently works for Novartis Institutes for BioMedical Research (NIBR).
David Auslander's role at Novartis Institutes for BioMedical Research (NIBR) is Senior Principal Scientist / Group Head.
David Auslander's email address is ***@novartis.com. To view David Auslander's full email address, please signup to ConnectPlex.
David Auslander works in the Major Drugs industry.
David Auslander's colleagues at Novartis Institutes for BioMedical Research (NIBR) are Rene Wyler, Dominic Ehrismann, Eusebio Manchado, Jean Quancard, Andrea Widhalm, Valerie Salazar, Brigitte Schiessl and others.
David Auslander's phone number is 617-871-8000
See more information about David Auslander